Last 12 months
Inside the activity.
2 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 1 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 1 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 08, 2025 Filed May 12, 2025 20:05 UTC |
Lin Lawrence Y.EVP, CFO and Treasurer
|
GrantCommon | 2,000 | $27.67 | $55,340.00 |
DisclosureSEC source: 0000950170-25-069158 · ownership.xml · nonDerivative · entry 1 Lin Lawrence Y. · CIK 0002045844 · EVP, CFO and Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 39,513 F1 · shares: Open market purchase. Read SEC document |
| May 08, 2025 Filed May 12, 2025 20:05 UTC |
Marotta JohnDirector · President and CEO
|
GrantCommon | 3,637.638 | $27.49 | $99,998.67 |
DisclosureSEC source: 0000950170-25-069157 · ownership.xml · nonDerivative · entry 1 Marotta John · CIK 0001882058 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 102,658.135 F1 · shares: Open market purchase. F2 · price: Represents the weighted average price for the shares purchased on May 8, 2025. The shares were purchased at per-share prices ranging from $27.31 to $27.97. The reporting person will provide to the SEC, the issuer and any stockholder, upon request, full information regarding the number of shares purchased or sold at each separate price. Read SEC document |
| May 08, 2025 Filed Jun 4, 2025 20:10 UTC Amendment |
Marotta JohnDirector · President and CEO
|
GrantCommon | 3,637.638 | $27.49 | $99,998.67 |
DisclosureSEC source: 0000950170-25-081626 · ownership.xml · nonDerivative · entry 1 Marotta John · CIK 0001882058 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 104,499.615 F1 · balance_after: The original Form 4, filed May 12, 2025, is being amended by this Form 4 Amendment solely to correct an administrative error. Following the 05/08/2025 acquisition of 3,637.638 shares, the Reporting Person's Amount of Securities Beneficially Owned was 104,499.615, not 102,658.135 as originally reported. Following the 05/09/2025 acquisition of 1,796.165 shares, the Amount of Securities Beneficially Owned was correctly reported as 106,295.780. Read SEC document |
| February 11, 2025 Filed Feb 13, 2025 21:10 UTC |
Lin Lawrence Y.EVP, CFO and Treasurer
|
GrantCommon | 2,200 | $46.00 | $101,200.00 |
DisclosureSEC source: 0000950170-25-019885 · ownership.xml · nonDerivative · entry 1 Lin Lawrence Y. · CIK 0002045844 · EVP, CFO and Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,513 F1 · shares: Open market purchase. Read SEC document |
| February 07, 2025 Filed Feb 11, 2025 21:48 UTC |
Koffey QuentinDirector
|
GrantCommon Stock | 4,040 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-011534 · tm256229-1_4seq1.xml · nonDerivative · entry 1 Koffey Quentin · CIK 0001984174 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,035 F1 · shares: Annual grant of unrestricted shares under the Issuer's 2020 Equity Incentive Plan in connection with the Reporting Person's service on the Issuer's Board of Directors (the "Board"). The number of shares was determined based on an annual grant amount of $215,000 and a price per share of $52.32 based on the average daily closing price for the 20 trading-day period immediately preceding and including February 7, 2025. F2 · price: No amount was paid upon grant of the shares. Read SEC document |
| February 07, 2025 Filed Feb 11, 2025 21:10 UTC |
Casal FrankDirector
|
GrantCommon | 5,168 | $52.32 | $270,389.76 |
DisclosureSEC source: 0000950170-25-017895 · ownership.xml · nonDerivative · entry 1 Casal Frank · CIK 0001891819 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,560 F1 · shares: Grant of unrestricted shares under the Company's 2020 Equity Incentive Plan. No amount was paid upon grant of the shares. Read SEC document |
| February 07, 2025 Filed Feb 11, 2025 21:10 UTC |
Malus Alan JDirector
|
GrantCommon | 4,040 | $52.32 | $211,372.80 |
DisclosureSEC source: 0000950170-25-017896 · ownership.xml · nonDerivative · entry 1 Malus Alan J · CIK 0001380163 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,035 F1 · shares: Grant of unrestricted shares under the Company's 2020 Equity Incentive Plan. No amount was paid upon grant of the shares. Read SEC document |
| February 07, 2025 Filed Feb 11, 2025 21:10 UTC |
Davis Robyn CDirector
|
GrantCommon | 4,040 | $52.32 | $211,372.80 |
DisclosureSEC source: 0000950170-25-017894 · ownership.xml · nonDerivative · entry 1 Davis Robyn C · CIK 0001580601 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,627 F1 · shares: Grant of unrestricted shares under the Company's 2020 Equity Incentive Plan. No amount was paid upon grant of the shares. Read SEC document |
| February 07, 2025 Filed Feb 11, 2025 21:10 UTC |
Nova Tina SusanDirector
|
GrantCommon | 4,040 | $52.32 | $211,372.80 |
DisclosureSEC source: 0000950170-25-017893 · ownership.xml · nonDerivative · entry 1 Nova Tina Susan · CIK 0001302605 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,109 F1 · shares: Grant of unrestricted shares under the Company's 2020 Equity Incentive Plan. No amount was paid upon grant of the shares. Read SEC document |
| February 07, 2025 Filed Feb 11, 2025 21:10 UTC |
Madaus Martin DDirector
|
GrantRestricted Stock Unit · Derivative | 4,040 | Not disclosed Strike: $0.00 | Not disclosed |
DisclosureSEC source: 0000950170-25-017898 · ownership.xml · derivative · entry 1 Madaus Martin D · CIK 0001310268 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,040 Underlying: Common Stock · 4,040 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of Azenta's common stock. The units are fully vested upon grant but the Reporting Person elected to have the settlement deferred until the later of his attainment of age 65 or his separation from service from the company. F2 · price: Grant of Restricted Stock Units under the Company's 2020 Equity Incentive Plan. No amount was paid upon grant of the units. F1 · derivative.exercise_date: Each restricted stock unit represents the right to receive one share of Azenta's common stock. The units are fully vested upon grant but the Reporting Person elected to have the settlement deferred until the later of his attainment of age 65 or his separation from service from the company. F1 · derivative.expiration_date: Each restricted stock unit represents the right to receive one share of Azenta's common stock. The units are fully vested upon grant but the Reporting Person elected to have the settlement deferred until the later of his attainment of age 65 or his separation from service from the company. Read SEC document |
| February 07, 2025 Filed Feb 11, 2025 21:10 UTC |
Doshi DipalDirector
|
GrantCommon | 4,040 | $52.32 | $211,372.80 |
DisclosureSEC source: 0000950170-25-017892 · ownership.xml · nonDerivative · entry 1 Doshi Dipal · CIK 0001613084 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,040 F1 · shares: Grant of unrestricted shares under the Company's 2020 Equity Incentive Plan. No amount was paid upon grant of the shares. Read SEC document |
| February 07, 2025 Filed Feb 11, 2025 21:10 UTC |
Cornog William LDirector
|
GrantRestricted Stock Unit · Derivative | 4,040 | Not disclosed Strike: $0.00 | Not disclosed |
DisclosureSEC source: 0000950170-25-017897 · ownership.xml · derivative · entry 1 Cornog William L · CIK 0001697415 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,040 Underlying: Common Stock · 4,040 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of Azenta's common stock. The units are fully vested upon grant but the Reporting Person elected to have the settlement deferred until the later of his attainment of age 65 or his separation from service from the company. F2 · price: Grant of Restricted Stock Units under the Company's 2020 Equity Incentive Plan. No amount was paid upon grant of the units. F1 · derivative.exercise_date: Each restricted stock unit represents the right to receive one share of Azenta's common stock. The units are fully vested upon grant but the Reporting Person elected to have the settlement deferred until the later of his attainment of age 65 or his separation from service from the company. F1 · derivative.expiration_date: Each restricted stock unit represents the right to receive one share of Azenta's common stock. The units are fully vested upon grant but the Reporting Person elected to have the settlement deferred until the later of his attainment of age 65 or his separation from service from the company. Read SEC document |
| February 07, 2025 Filed Feb 11, 2025 21:10 UTC |
McLaughlin EricaDirector
|
GrantCommon | 4,040 | $52.32 | $211,372.80 |
DisclosureSEC source: 0000950170-25-017891 · ownership.xml · nonDerivative · entry 1 McLaughlin Erica · CIK 0001740348 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,858 F1 · shares: Grant of unrestricted shares under the Company's 2020 Equity Incentive Plan. No amount was paid upon grant of the shares. Read SEC document |
| February 03, 2025 Filed Feb 4, 2025 21:10 UTC |
Hughes ViolettaVP, Chief Accounting Officer
|
SaleCommon | 317 | $52.97 | $16,791.49 |
DisclosureSEC source: 0000950170-25-013430 · ownership.xml · nonDerivative · entry 1 Hughes Violetta · CIK 0001991429 · VP, Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,603 F1 · shares: The sale of shares by the reporting person to satisfy the reporting person's obligations with respect to withholding taxes in connection with the vesting on January 31, 2025 of 894 restricted stock units held by the reporting person. Read SEC document |
| January 31, 2025 Filed Feb 4, 2025 21:10 UTC |
Zhou GingerSVP and General Manager, Genom
|
PurchaseCommon | 417 | $45.88 | $19,131.96 |
DisclosureSEC source: 0000950170-25-013428 · ownership.xml · nonDerivative · entry 1 Zhou Ginger · CIK 0001953934 · SVP and General Manager, Genom 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,916 F1 · shares: Purchase by Reporting Person under the Azenta, Inc. 2017 Employee Stock Purchase Plan. The purchase of shares was exempt from Section 16(b) of the Securities Exchange Act of 1934 (the "Exchange Act") pursuant to Rule 16b-3(c) under the Exchange Act Read SEC document |
| December 05, 2024 Filed Dec 9, 2024 21:10 UTC |
Lin Lawrence Y.EVP, CFO and Treasurer
|
GrantCommon | 5,768 | $45.00 | $259,560.00 |
DisclosureSEC source: 0000950170-24-134525 · ownership.xml · nonDerivative · entry 2 Lin Lawrence Y. · CIK 0002045844 · EVP, CFO and Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,313 F1 · shares: Represents two grants of restricted stock units to the Reporting Person under the Company's Equity Incentive Plan, one grant of 23,045 units subject to time-based vesting and will vest 33% per year for three years, beginning on December 5, 2025 and another grant of 5,768 units subject to time-based vesting and will vest 50% per year for two years, beginning on December 5, 2025. No amount was paid upon grant of the units. Read SEC document |
| December 05, 2024 Filed Dec 9, 2024 21:10 UTC |
Lin Lawrence Y.EVP, CFO and Treasurer
|
GrantCommon | 23,045 | $45.00 | $1,037,025.00 |
DisclosureSEC source: 0000950170-24-134525 · ownership.xml · nonDerivative · entry 1 Lin Lawrence Y. · CIK 0002045844 · EVP, CFO and Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,545 F1 · shares: Represents two grants of restricted stock units to the Reporting Person under the Company's Equity Incentive Plan, one grant of 23,045 units subject to time-based vesting and will vest 33% per year for three years, beginning on December 5, 2025 and another grant of 5,768 units subject to time-based vesting and will vest 50% per year for two years, beginning on December 5, 2025. No amount was paid upon grant of the units. Read SEC document |
| December 04, 2024 Filed Dec 5, 2024 21:10 UTC |
Wang David DongSVP & GM, SMS
|
Disposition to issuerCommon | 140 | $46.65 | $6,531.00 |
DisclosureSEC source: 0000950170-24-133678 · ownership.xml · nonDerivative · entry 1 Wang David Dong · CIK 0002000563 · SVP & GM, SMS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,974 F1 · shares: The sale of shares by the reporting person to satisfy the reporting person's obligations with respect to withholding taxes in connection with the vesting on December 2, 2024 of 470 restricted stock units held by the reporting person. Read SEC document |
| November 19, 2024 Filed Nov 19, 2024 21:10 UTC |
Marotta JohnDirector · President and CEO
|
PurchaseCommon | 1,250 | $40.67 | $50,837.50 |
DisclosureSEC source: 0000950170-24-128592 · ownership.xml · nonDerivative · entry 3 Marotta John · CIK 0001882058 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 100,861.977 Read SEC document |
| November 19, 2024 Filed Nov 19, 2024 21:00 UTC |
Madaus Martin DDirector
|
PurchaseCommon | 4,940 | $40.77 | $201,403.80 |
DisclosureSEC source: 0000950170-24-128541 · ownership.xml · nonDerivative · entry 1 Madaus Martin D · CIK 0001310268 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,405 F1 · price: Represents the weighted average price for the shares purchased. The shares were purchased at per-share prices ranging from $40.59 and $40.90. The reporting person will provide to the SEC, the issuer and any stockholder, upon request, full information regarding the number of shares purchased or sold at each separate price. Read SEC document |
| November 19, 2024 Filed Nov 21, 2024 21:10 UTC |
Cueto HermanEVP, Chief Financial Officer
|
SaleCommon | 712 | $40.07 | $28,529.84 |
DisclosureSEC source: 0000950170-24-129719 · ownership.xml · nonDerivative · entry 1 Cueto Herman · CIK 0001997198 · EVP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,892 F1 · shares: Represents the sale of shares by the reporting person to satisfy the reporting person's obligations with respect to withholding taxes in connection with the vesting on November 15, 2024 of 1,909 restricted stock units from one grant held by the reporting person and previously reported on Form 4. F2 · price: Represents the weighted average price for shares sold between November 18, 2024 and November 19, 2024 at a range between $38.83 and $41.48. The reporting person will provide to the Securities and Exchange Commission, the issuer and any stockholder, upon request, full information regarding the number of shares purchased or sold at each separate price. Read SEC document |
| November 19, 2024 Filed Nov 21, 2024 21:10 UTC |
Pirogova OlgaSVP and CHRO
|
SaleCommon | 548 | $40.07 | $21,958.36 |
DisclosureSEC source: 0000950170-24-129724 · ownership.xml · nonDerivative · entry 1 Pirogova Olga · CIK 0002000496 · SVP and CHRO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,373 F1 · shares: Represents the sale of shares by the reporting person to satisfy the reporting person's obligations with respect to withholding taxes in connection with the vesting on November 15, 2024 of 1,069 restricted stock units from one grant held by the reporting person and previously reported on Form 4. F2 · price: Represents the weighted average price for shares sold between November 18, 2024 and November 19, 2024 at a range between $38.83 and $41.48. The reporting person will provide to the Securities and Exchange Commission, the issuer and any stockholder, upon request, full information regarding the number of shares purchased or sold at each separate price. Read SEC document |
| November 19, 2024 Filed Nov 21, 2024 21:10 UTC |
Hughes ViolettaVP, Chief Accounting Officer
|
SaleCommon | 163 | $40.07 | $6,531.41 |
DisclosureSEC source: 0000950170-24-129723 · ownership.xml · nonDerivative · entry 1 Hughes Violetta · CIK 0001991429 · VP, Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,920 F1 · shares: Represents the sale of shares by the reporting person to satisfy the reporting person's obligations with respect to withholding taxes in connection with the vesting on November 15, 2024 of 459 restricted stock units from one grant held by the reporting person and previously reported on Form 4. F2 · price: Represents the weighted average price for shares sold between November 18, 2024 and November 19, 2024 at a range between $38.83 and $41.48. The reporting person will provide to the Securities and Exchange Commission, the issuer and any stockholder, upon request, full information regarding the number of shares purchased or sold at each separate price. Read SEC document |
| November 19, 2024 Filed Nov 21, 2024 21:10 UTC |
Zhou GingerSVP and General Manager, Genom
|
SaleCommon | 491 | $40.07 | $19,674.37 |
DisclosureSEC source: 0000950170-24-129722 · ownership.xml · nonDerivative · entry 1 Zhou Ginger · CIK 0001953934 · SVP and General Manager, Genom 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,499 F1 · shares: Represents the sale of shares by the reporting person to satisfy the reporting person's obligations with respect to withholding taxes in connection with the vesting on November 15, 2024 of 1,844 restricted stock units from three grants held by the reporting person and previously reported on Form 4. F2 · price: Represents the weighted average price for shares sold between November 18, 2024 and November 19, 2024 at a range between $38.83 and $41.48. The reporting person will provide to the Securities and Exchange Commission, the issuer and any stockholder, upon request, full information regarding the number of shares purchased or sold at each separate price. Read SEC document |
| November 19, 2024 Filed Nov 21, 2024 21:10 UTC |
Wang David DongSVP & GM, SMS
|
SaleCommon | 348 | $40.07 | $13,944.36 |
DisclosureSEC source: 0000950170-24-129721 · ownership.xml · nonDerivative · entry 1 Wang David Dong · CIK 0002000563 · SVP & GM, SMS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,114 F1 · shares: Represents the sale of shares by the reporting person to satisfy the reporting person's obligations with respect to withholding taxes in connection with the vesting on November 15, 2024 of 1,069 restricted stock units from one grant held by the reporting person and previously reported on Form 4. F2 · price: Represents the weighted average price for shares sold between November 18, 2024 and November 19, 2024 at a range between $38.83 and $41.48. The reporting person will provide to the Securities and Exchange Commission, the issuer and any stockholder, upon request, full information regarding the number of shares purchased or sold at each separate price. Read SEC document |
| November 19, 2024 Filed Nov 21, 2024 21:10 UTC |
Joseph JasonSVP, General Counsel, Secy.
|
SaleCommon | 1,139 | $40.07 | $45,639.73 |
DisclosureSEC source: 0000950170-24-129720 · ownership.xml · nonDerivative · entry 1 Joseph Jason · CIK 0001485448 · SVP, General Counsel, Secy. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 112,564 F1 · shares: Represents the sale of shares by the reporting person to satisfy the reporting person's obligations with respect to withholding taxes in connection with the vesting on November 15, 2024 of 3,638 restricted stock units from three grants held by the reporting person and previously reported on Form 4. F2 · price: Represents the weighted average price for shares sold between November 18, 2024 and November 19, 2024 at a range between $38.83 and $41.48. The reporting person will provide to the Securities and Exchange Commission, the issuer and any stockholder, upon request, full information regarding the number of shares purchased or sold at each separate price. Read SEC document |
| November 18, 2024 Filed Nov 19, 2024 21:10 UTC |
Marotta JohnDirector · President and CEO
|
PurchaseCommon | 12,716.977 | $39.48 | $502,066.25 |
DisclosureSEC source: 0000950170-24-128592 · ownership.xml · nonDerivative · entry 2 Marotta John · CIK 0001882058 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 99,611.977 F2 · price: Represents the weighted average price for the shares purchased. The shares were purchased at per-share prices ranging from $39.35 to $39.51. The reporting person will provide to the SEC, the issuer and any stockholder, upon request, full information regarding the number of shares purchased or sold at each separate price. Read SEC document |
| November 18, 2024 Filed Nov 19, 2024 21:10 UTC |
Cornog William LDirector
|
PurchaseCommon | 12,500 | $39.60 | $495,000.00 |
DisclosureSEC source: 0000950170-24-128588 · ownership.xml · nonDerivative · entry 1 Cornog William L · CIK 0001697415 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 14,755 F1 · price: Represents the weighted average price for the shares purchased. The shares were purchased at per-share prices ranging from $39.59 to $39.62. The reporting person will provide to the SEC, the issuer and any stockholder, upon request, full information regarding the number of shares purchased or sold at each separate price. F2 · ownership.nature: Reflects shares held in trusts beneficially owned by the reporting person, of which the reporting person, his spouse and children are beneficiaries, and as to which the reporting person is the trustee and has investment and voting power. Read SEC document |
| November 18, 2024 Filed Nov 19, 2024 21:10 UTC |
HIRSCH DIDIERDirector
|
PurchaseCommon | 1,000 | $39.50 | $39,500.00 |
DisclosureSEC source: 0000950170-24-128589 · ownership.xml · nonDerivative · entry 1 HIRSCH DIDIER · CIK 0001226464 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,465 Read SEC document |
| November 15, 2024 Filed Nov 19, 2024 21:10 UTC |
Marotta JohnDirector · President and CEO
|
GrantCommon | 83,622 | $41.51 | $3,471,149.22 |
DisclosureSEC source: 0000950170-24-128592 · ownership.xml · nonDerivative · entry 1 Marotta John · CIK 0001882058 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 86,895 F1 · shares: Grant of restricted stock units to the Reporting Person under the Company's Equity Incentive Plan. No amount was paid upon grant of the units. The units are subject to time-based vesting and will vest 33-1/3% per year, beginning on November 15, 2025. Read SEC document |
| November 15, 2024 Filed Nov 19, 2024 21:10 UTC |
Pirogova OlgaSVP and CHRO
|
GrantCommon | 10,381 | $41.51 | $430,915.31 |
DisclosureSEC source: 0000950170-24-128593 · ownership.xml · nonDerivative · entry 1 Pirogova Olga · CIK 0002000496 · SVP and CHRO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,921 F1 · shares: Grant of restricted stock units to the Reporting Person under the Company's Equity Incentive Plan. No amount was paid upon grant of the units. The units are subject to time-based vesting and will vest 33-1/3% per year, beginning on November 15, 2025. Read SEC document |
| November 15, 2024 Filed Nov 19, 2024 21:10 UTC |
Joseph JasonSVP, General Counsel, Secy.
|
GrantCommon | 13,841 | $41.51 | $574,539.91 |
DisclosureSEC source: 0000950170-24-128591 · ownership.xml · nonDerivative · entry 1 Joseph Jason · CIK 0001485448 · SVP, General Counsel, Secy. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 113,703 F1 · shares: Grant of restricted stock units to the Reporting Person under the Company's Equity Incentive Plan. No amount was paid upon grant of the units. The units are subject to time-based vesting and will vest 33-1/3% per year, beginning on November 15, 2025. Read SEC document |
| November 15, 2024 Filed Nov 19, 2024 21:10 UTC |
Hughes ViolettaVP, Chief Accounting Officer
|
GrantCommon | 6,921 | $41.51 | $287,290.71 |
DisclosureSEC source: 0000950170-24-128590 · ownership.xml · nonDerivative · entry 1 Hughes Violetta · CIK 0001991429 · VP, Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,083 F1 · shares: Grant of restricted stock units to the Reporting Person under the Company's Equity Incentive Plan. No amount was paid upon grant of the units. The units are subject to time-based vesting and will vest 33-1/3% per year, beginning on November 15, 2025. Read SEC document |
| November 15, 2024 Filed Nov 19, 2024 21:10 UTC |
Wang David DongSVP & GM, SMS
|
GrantCommon | 8,651 | $41.51 | $359,103.01 |
DisclosureSEC source: 0000950170-24-128587 · ownership.xml · nonDerivative · entry 1 Wang David Dong · CIK 0002000563 · SVP & GM, SMS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,462 F1 · shares: Grant of restricted stock units to the Reporting Person under the Company's Equity Incentive Plan. No amount was paid upon grant of the units. The units are subject to time-based vesting and will vest 33-1/3% per year, beginning on November 15, 2025. Read SEC document |
| November 15, 2024 Filed Nov 19, 2024 21:10 UTC |
Zhou GingerSVP and General Manager, Genom
|
GrantCommon | 8,651 | $41.51 | $359,103.01 |
DisclosureSEC source: 0000950170-24-128586 · ownership.xml · nonDerivative · entry 1 Zhou Ginger · CIK 0001953934 · SVP and General Manager, Genom 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,990 F1 · shares: Grant of restricted stock units to the Reporting Person under the Company's Equity Incentive Plan. No amount was paid upon grant of the units. The units are subject to time-based vesting and will vest 33-1/3% per year, beginning on November 15, 2025. Read SEC document |
| November 06, 2024 Filed Nov 8, 2024 21:20 UTC |
Cornog William LDirector
|
Disposition to issuerCommon | 995 | $46.52 | $46,287.40 |
DisclosureSEC source: 0000950170-24-124120 · ownership.xml · nonDerivative · entry 1 Cornog William L · CIK 0001697415 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,255 F1 · shares: Grant of unrestricted shares to the reporting person in connection with the reporting person's appointment to the Board of Directors. No amount was paid upon grant of the shares. Read SEC document |
| November 06, 2024 Filed Nov 8, 2024 13:19 UTC |
Koffey QuentinDirector
|
GrantCommon Stock | 995 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-115613 · tm2427880-1_4seq1.xml · nonDerivative · entry 1 Koffey Quentin · CIK 0001984174 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 995 F1 · shares: Pro-rated annual grant of unrestricted shares under the Issuer's 2020 Equity Incentive Plan in connection with the Reporting Person joining the Issuer's Board of Directors (the "Board") on November 1, 2024. The number of shares was determined based on a pro-rated annual grant amount of $43,185 and a price per share of $43.41 based on the average daily closing price for the 20 trading-day period immediately preceding and including November 6, 2024. F2 · price: No amount was paid upon grant of the shares. Read SEC document |
| November 06, 2024 Filed Nov 14, 2024 21:27 UTC |
Malus Alan JDirector
|
Disposition to issuerCommon | 995 | $46.52 | $46,287.40 |
DisclosureSEC source: 0000950170-24-127105 · ownership.xml · nonDerivative · entry 1 Malus Alan J · CIK 0001380163 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 995 F1 · shares: Grant of unrestricted shares to the reporting person in connection with the reporting person's appointment to the Board of Directors. No amount was paid upon grant of the shares. Read SEC document |
| October 17, 2024 Filed Oct 21, 2024 20:10 UTC |
Cueto HermanEVP, Chief Financial Officer
|
SaleCommon | 1,595 | $43.68 | $69,669.60 |
DisclosureSEC source: 0000950170-24-115940 · ownership.xml · nonDerivative · entry 1 Cueto Herman · CIK 0001997198 · EVP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,604 F1 · shares: The sale of shares by the reporting person to satisfy the reporting person's obligations with respect to withholding taxes in connection with the vesting on October 16, 2024 of 9,163 restricted stock units held by the reporting person. Read SEC document |
| September 09, 2024 Filed Sep 11, 2024 20:10 UTC |
Marotta JohnDirector · President and CEO
|
GrantCommon | 3,273 | $46.15 | $151,048.95 |
DisclosureSEC source: 0000950170-24-105506 · ownership.xml · nonDerivative · entry 1 Marotta John · CIK 0001882058 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,273 F1 · shares: Grant of restricted stock units to the Reporting Person under the Company's Equity Incentive Plan. No amount was paid upon grant of the units. The units will vest over three years, 33% on September 9, 2025, 33% on September 9, 2026, and 33% on September 9, 2027. Read SEC document |
| August 09, 2024 Filed Aug 13, 2024 20:10 UTC |
Cueto HermanEVP, Chief Financial Officer
|
GrantCommon | 11,309 | $55.27 | $625,048.43 |
DisclosureSEC source: 0000950170-24-096207 · ownership.xml · nonDerivative · entry 1 Cueto Herman · CIK 0001997198 · EVP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,199 F1 · shares: Grant of restricted stock units to the Reporting Person under the Company's Equity Incentive Plan. No amount was paid upon grant of the units.The units will vest over two years, 50% on August 9, 2025 and 50% on August 9, 2026. Read SEC document |
| August 09, 2024 Filed Aug 13, 2024 20:10 UTC |
Wang David DongSVP & GM, SMS
|
GrantCommon | 6,333 | $55.27 | $350,024.91 |
DisclosureSEC source: 0000950170-24-096206 · ownership.xml · nonDerivative · entry 1 Wang David Dong · CIK 0002000563 · SVP & GM, SMS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,811 F1 · shares: Grant of restricted stock units to the Reporting Person under the Company's Equity Incentive Plan. No amount was paid upon grant of the units.The units will vest over two years, 50% on August 9, 2025 and 50% on August 9, 2026. Read SEC document |
| August 09, 2024 Filed Aug 13, 2024 20:10 UTC |
Pirogova OlgaSVP and CHRO
|
GrantCommon | 6,333 | $55.27 | $350,024.91 |
DisclosureSEC source: 0000950170-24-096205 · ownership.xml · nonDerivative · entry 1 Pirogova Olga · CIK 0002000496 · SVP and CHRO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,540 F1 · shares: Grant of restricted stock units to the Reporting Person under the Company's Equity Incentive Plan. No amount was paid upon grant of the units.The units will vest over two years, 50% on August 9, 2025 and 50% on August 9, 2026. Read SEC document |
| August 09, 2024 Filed Aug 13, 2024 20:10 UTC |
Joseph JasonSVP, General Counsel, Secy.
|
GrantCommon | 10,856 | $55.27 | $600,011.12 |
DisclosureSEC source: 0000950170-24-096203 · ownership.xml · nonDerivative · entry 1 Joseph Jason · CIK 0001485448 · SVP, General Counsel, Secy. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 99,862 F1 · shares: Grant of restricted stock units to the Reporting Person under the Company's Equity Incentive Plan. No amount was paid upon grant of the units.The units will vest over two years, 50% on August 9, 2025 and 50% on August 9, 2026. Read SEC document |
| August 09, 2024 Filed Aug 13, 2024 20:10 UTC |
Zhou GingerSVP and General Manager, Genom
|
GrantCommon | 6,333 | $55.27 | $350,024.91 |
DisclosureSEC source: 0000950170-24-096202 · ownership.xml · nonDerivative · entry 1 Zhou Ginger · CIK 0001953934 · SVP and General Manager, Genom 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,339 F1 · shares: Grant of restricted stock units to the Reporting Person under the Company's Equity Incentive Plan. No amount was paid upon grant of the units.The units will vest over two years, 50% on August 9, 2025 and 50% on August 9, 2026. Read SEC document |
| August 01, 2024 Filed Aug 1, 2024 20:10 UTC |
Joseph JasonSVP, General Counsel, Secy.
|
Disposition to issuerCommon | 1,000 | $62.05 | $62,050.00 |
DisclosureSEC source: 0000950170-24-089280 · ownership.xml · nonDerivative · entry 1 Joseph Jason · CIK 0001485448 · SVP, General Counsel, Secy. 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 89,006 F1 · shares: The sales reported on this line item were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 7, 2023. Read SEC document |
| July 25, 2024 Filed Jul 29, 2024 20:05 UTC |
Joseph JasonSVP, General Counsel, Secy.
|
Disposition to issuerCommon | 3,000 | $60.00 | $180,000.00 |
DisclosureSEC source: 0000950170-24-087278 · ownership.xml · nonDerivative · entry 1 Joseph Jason · CIK 0001485448 · SVP, General Counsel, Secy. 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 90,006 F1 · shares: The sales reported on this line item were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 7, 2023. Read SEC document |
| May 20, 2024 Filed May 22, 2024 20:10 UTC |
Hughes ViolettaVP, Chief Accounting Officer
|
Disposition to issuerCommon | 584 | $51.36 | $29,994.24 |
DisclosureSEC source: 0000950170-24-063492 · ownership.xml · nonDerivative · entry 1 Hughes Violetta · CIK 0001991429 · VP, Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,162 Read SEC document |
| April 01, 2024 Filed Apr 2, 2024 20:10 UTC |
Joseph JasonSVP, General Counsel, Secy.
|
Disposition to issuerCommon | 1,000 | $60.15 | $60,150.00 |
DisclosureSEC source: 0000950170-24-040153 · ownership.xml · nonDerivative · entry 1 Joseph Jason · CIK 0001485448 · SVP, General Counsel, Secy. 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 93,006 F1 · shares: The sales reported on this line item were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 7, 2023. Read SEC document |
| March 08, 2024 Filed Mar 11, 2024 20:10 UTC |
Joseph JasonSVP, General Counsel, Secy.
|
Disposition to issuerCommon | 4,000 | $67.50 | $270,000.00 |
DisclosureSEC source: 0000950170-24-029238 · ownership.xml · nonDerivative · entry 4 Joseph Jason · CIK 0001485448 · SVP, General Counsel, Secy. 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 94,006 F1 · shares: The sales reported on this line item were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 7, 2023. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.